Leveraging Real-World Data from the IRIS Registry to Improve Diversity in Ophthalmology Clinical Trials
Through an exclusive partnership with the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight), Verana Health is leveraging real-world data (RWD) to help address the challenges of diversifying clinical trials.
Request your copy of this white paper to learn how RWD can help:
- Define more inclusive trial criteria by providing insights into the demographics and health status of a broader patient population
- Identify geographic areas and demographic groups with higher disease prevalence and lower trial participation rates
- Inform trial design decisions by highlighting the preferences and barriers faced by different demographic groups
Get Your Copy Today
Please do not send any Protected Health Information (PHI) when submitting this form. This form is not encrypted and it is not a suitable method for transmitting PHI. Any PHI sent to Verana Health via this form is deemed to be authorized by the subject of the PHI.
